How sleep patterns affect substance use risk in teenagers
Circadian rhythms and homeostatic sleep regulation during adolescence: Implications for reward, cognitive control, and substance use risk
This study is looking at how sleep patterns and body clocks affect the risk of substance use in teens aged 12 to 20, hoping to find ways to help prevent these issues by understanding how sleep problems can influence behavior and decision-making.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10892093 on NIH RePORTER |
What this research studies
This research investigates the relationship between circadian rhythms, sleep regulation, and the risk of substance use disorders in adolescents aged 12 to 20. By examining how sleep disturbances and changes in reward and cognitive control systems during this critical developmental period influence substance use, the study aims to identify modifiable risk factors. The researchers will use a controlled environment to analyze the effects of sleep patterns on behavior and cognitive functions, providing insights into potential prevention strategies for substance use in teens.
Who could benefit from this research
Good fit: Ideal candidates for participation are adolescents aged 12 to 20 who may be experiencing sleep disturbances or are at risk for substance use.
Not a fit: Patients outside the age range of 12 to 20 or those without sleep issues or substance use risk may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention and intervention strategies for substance use disorders in adolescents.
How similar studies have performed: Previous research has shown that sleep patterns significantly influence adolescent behavior and substance use, suggesting that this approach is grounded in established findings.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Franzen, Peter L — University of Pittsburgh at Pittsburgh
- Study coordinator: Franzen, Peter L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.